Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021 18 8
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Siltuximab Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/29/2021 2 1
Ruxolitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021 10 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Capreomycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 2 0
RBD immunogen Potential treatment - pre-clinical evidence Experimental Vaccine Mar/11/2021 2 0
Saquinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/26/2020 10 1
Excel (.xslx) CSV (.csv)